Anika Therapeutics (ANIK) Competitors $17.28 +0.35 (+2.07%) Closing price 04:00 PM EasternExtended Trading$18.08 +0.80 (+4.62%) As of 04:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ANIK vs. CERS, OSUR, UTMD, WST, COO, ALGN, MMSI, ICUI, XRAY, and HAEShould you be buying Anika Therapeutics stock or one of its competitors? The main competitors of Anika Therapeutics include Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry. Anika Therapeutics vs. Cerus OraSure Technologies Utah Medical Products West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems ICU Medical DENTSPLY SIRONA Haemonetics Anika Therapeutics (NASDAQ:ANIK) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, community ranking, dividends, earnings, profitability, valuation and institutional ownership. Which has better valuation & earnings, ANIK or CERS? Cerus has lower revenue, but higher earnings than Anika Therapeutics. Cerus is trading at a lower price-to-earnings ratio than Anika Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnika Therapeutics$166.66M1.52-$82.67M-$6.65-2.60Cerus$156.37M2.35-$37.49M-$0.11-18.00 Does the MarketBeat Community believe in ANIK or CERS? Cerus received 266 more outperform votes than Anika Therapeutics when rated by MarketBeat users. Likewise, 72.30% of users gave Cerus an outperform vote while only 64.33% of users gave Anika Therapeutics an outperform vote. CompanyUnderperformOutperformAnika TherapeuticsOutperform Votes30364.33% Underperform Votes16835.67% CerusOutperform Votes56972.30% Underperform Votes21827.70% Is ANIK or CERS more profitable? Cerus has a net margin of -11.19% compared to Anika Therapeutics' net margin of -59.40%. Anika Therapeutics' return on equity of -2.22% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Anika Therapeutics-59.40% -2.22% -1.75% Cerus -11.19%-37.90%-10.35% Which has more volatility & risk, ANIK or CERS? Anika Therapeutics has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Do insiders and institutionals hold more shares of ANIK or CERS? 91.5% of Anika Therapeutics shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 7.9% of Anika Therapeutics shares are held by company insiders. Comparatively, 3.4% of Cerus shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer ANIK or CERS? In the previous week, Cerus had 4 more articles in the media than Anika Therapeutics. MarketBeat recorded 5 mentions for Cerus and 1 mentions for Anika Therapeutics. Anika Therapeutics' average media sentiment score of 1.89 beat Cerus' score of 0.65 indicating that Anika Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Anika Therapeutics Very Positive Cerus Positive Do analysts rate ANIK or CERS? Anika Therapeutics presently has a consensus price target of $24.50, indicating a potential upside of 41.78%. Cerus has a consensus price target of $3.63, indicating a potential upside of 83.08%. Given Cerus' stronger consensus rating and higher possible upside, analysts plainly believe Cerus is more favorable than Anika Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anika Therapeutics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Cerus 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 SummaryCerus beats Anika Therapeutics on 11 of the 18 factors compared between the two stocks. Get Anika Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANIK vs. The Competition Export to ExcelMetricAnika TherapeuticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$253.15M$4.91B$5.61B$9.12BDividend YieldN/A52.56%5.36%3.98%P/E Ratio-2.6026.4289.5417.51Price / Sales1.5253.761,227.0083.27Price / Cash3.3052.0644.3037.67Price / Book1.198.245.124.72Net Income-$82.67M$13.79M$117.78M$224.62M7 Day Performance5.56%0.19%1.86%-0.42%1 Month Performance6.34%9.80%7.95%3.57%1 Year Performance-29.53%45.36%26.57%19.11% Anika Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANIKAnika Therapeutics4.037 of 5 stars$17.28+2.1%$24.50+41.8%-32.5%$253.15M$166.66M-2.60300CERSCerus2.7109 of 5 stars$2.15+8.9%$3.63+69.0%-6.3%$400.21M$156.37M-19.59290Short Interest ↑OSUROraSure Technologies4.4475 of 5 stars$4.11+2.4%$5.50+34.0%-50.1%$306.19M$405.47M27.37840Analyst DowngradeUTMDUtah Medical Products2.8419 of 5 stars$64.31+2.2%N/A-25.9%$219.03M$50.22M15.13180Earnings ReportUpcoming EarningsWSTWest Pharmaceutical Services4.7416 of 5 stars$343.77-0.4%$430.20+25.1%-8.2%$24.93B$2.95B51.0810,600Dividend AnnouncementShort Interest ↑COOCooper Companies2.4795 of 5 stars$99.26+1.6%$117.00+17.9%+3.7%$19.81B$3.90B50.9016,000ALGNAlign Technology4.8939 of 5 stars$229.43-1.7%$267.45+16.6%-17.0%$17.08B$3.86B39.0521,610Short Interest ↓News CoverageMMSIMerit Medical Systems4.5159 of 5 stars$105.29+0.6%$108.10+2.7%+35.2%$6.14B$1.26B51.616,950Analyst ForecastAnalyst RevisionNews CoveragePositive NewsICUIICU Medical4.5391 of 5 stars$172.19-0.1%$199.67+16.0%+75.1%$4.22B$2.26B-37.6814,000Short Interest ↑XRAYDENTSPLY SIRONA4.8332 of 5 stars$19.61+0.4%$26.67+36.0%-44.6%$3.90B$3.97B-9.4715,000Analyst ForecastHAEHaemonetics4.6712 of 5 stars$70.68-0.2%$108.78+53.9%-15.9%$3.55B$1.31B29.303,657Short Interest ↑ Related Companies and Tools Related Companies Cerus Alternatives OraSure Technologies Alternatives Utah Medical Products Alternatives West Pharmaceutical Services Alternatives Cooper Companies Alternatives Align Technology Alternatives Merit Medical Systems Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives Haemonetics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ANIK) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrump’s back in the oval office. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. And he says 2025 could be...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anika Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANIK Stock Alerts